Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Arthritis Advocacy Spotlights the Military: Veterans, including a rheumatologist, educate lawmakers about arthritis’ impact & the need for research funding

Susan Bernstein  |  February 22, 2019

Moderator Steve Smith, AF Volunteer, Commander, U.S. Navy (Retired)
The event’s moderator, retired U.S. Navy Commander and AF volunteer advocate Steve Smith, stressed that both arthritis funding and awareness need to be higher to have a positive impact on the health of both active service members and veterans.

“Arthritis funding is rather limited from year to year at the DoD. It’s critical that policymakers know that arthritis is the No. 1 cause of disability2 among our military veterans and that research to identify joint injury management techniques and slow progression of the disease will benefit everyone,” said Cmdr. Smith. “The impact on the DoD and Veterans Administration budgets, as a consequence of this disease, will only grow over the coming decades.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

There is an urgent need for better arthritis treatment for active duty troops, said Cmdr. Smith. “They deserve the best care available to ensure they can fulfill their mission and retire on their own terms, rather than letting a disease like arthritis take them out of service.” Because arthritis is so prevalent throughout the population, more research funding will ultimately benefit everyone, he added.

Panelist Bill Goulet, AF Volunteer, U.S. Navy Veteran
Fellow panelist Bill Goulet, an AF volunteer advocate and a U.S. Navy veteran, says he participated to help inform lawmakers, as well as new recruits and active military service members, about how to manage arthritis, including proper nutrition, exercise, training, equipment and treatment.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“As prevalent as it is, arthritis is a fairly silent, debilitating disease,” says Mr. Goulet. “I believe it is important to give it a voice and draw attention to the far-reaching negative aspects of arthritis and the lives it affects, both those afflicted, and their caregivers and families.”

More arthritis research funding in the DoD budget could support the study of new treatments and preventive interventions to improve quality of life for people in and after military service, he says.

“This should significantly reduce the financial burden of arthritis treatment after joints are damaged and worn out,” he says. “Hopefully, the result will be a stronger military, and reduced post-military service healthcare and financial burden.”

Ongoing Advocacy
While one high-profile event may have a strong impact on members of Congress, Dr. Edgerton encourages ACR and ARP members to engage in ongoing advocacy with their local and state lawmakers.

“ACR and ARP members are respected as leaders in their fields. With a shrinking rheumatology workforce, society depends on the ever smaller number of rheumatology voices for guidance on issues such as regulatory policy and legislation,” says Dr. Edgerton.3“Advocacy at each level—local community, state and national—is important in tackling issues at the appropriate stop, such as state legislature versus the halls of Congress, and also builds support for rheumatology causes.”

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Arthritis 101Department of Defense (DoD)DoD research funding

Related Articles

    ACR Advocates for Dedicated Department of Defense Arthritis Research Funding

    January 16, 2020

    The ACR and RheumPAC are working to secure an annual allocation of $20 million dedicated to research on arthritis prevention and treatment in the Congressionally Directed Medical Research Program budget.

    ACR Hosts Arthritis 101 Briefing on Capitol Hill

    February 3, 2017

    On Jan. 31, the ACR partnered with the Arthritis Foundation to host an Arthritis 101 Congressional briefing on Capitol Hill. Panelists educated new and returning members of Congress and their staffers about arthritis and other rheumatic diseases, the cost and impact of rheumatic disease to constituents and the U.S. healthcare system, and current policy challenges…

    ACR Partners with Veteran Groups to Call for Dedicated Department of Defense Arthritis Funding

    March 5, 2020

    Twenty-five veteran organizations have signed a letter to Congress supporting the ACR’s request for dedicated DOD arthritis research funds.

    Dusty Trades: Inorganic Dust Exposure During Military Service May Be an Occupational Risk Factor for RA

    October 7, 2021

    Mounting evidence indicates that exposure to inorganic dust is a risk factor for the development of autoimmune diseases. According to a recent study, dust exposure during military service in dusty environments represents an occupational and environmental risk and was associated with a 10% increased risk of developing RA.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences